Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OFCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
GEO DataSets Profile neighbors
LIPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPB41L4A-AS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ASIC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL1RN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABRB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APCDD1L-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSNAXIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on